N. Miyasaka - Concepedia

Author

N. Miyasaka

Tokyo Medical and Dental University

Also Known As

N MIYASAKA, N Miyasaka, N. MIYASAKA, N. Miyasaka, NAOYUKI MIYASAKA, Nobuo Aoki, Nobuyuki Miyasaka

111

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical and Dental University The University of Tokyo Saitama Medical University Social Insurance Saitama Chuo Hospital Tokyo Women's Medical University

About

N. Miyasaka is an author at Tokyo Medical and Dental University specializing in immunology, medicine, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.5K
2	Allergy	8	8	618
3	Cell Biology	8	8	352
4	Clinical Immunology	3	3	193
5	Natural Sciences	1	1	86

N. Miyasaka

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab Jun Hashimoto, N. Miyasaka, Kazuhiko Yamamoto, Annals of the Rheumatic Diseases	2007	739
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. Hiroshi Sakurai, Hitoshi Kohsaka, Meng‐Fan Liu, Journal of Clinical Investigation Synthase ExpressionNitric OxideImmunologyInflammatory ArthritisOxidative Stress	1995	391
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study Naoki Nishimoto, N. Miyasaka, Kazuhiko Yamamoto, Annals of the Rheumatic Diseases	2008	334
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study Yoshiya Tanaka, Tsutomu Takeuchi, Tsuneyo Mimori, Annals of the Rheumatic Diseases	2010	278
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus N. Miyasaka, Tsukasa Nakamura, I. Jon Russell, Clinical Immunology and Immunopathology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseLupus	1984	157
Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. N. Miyasaka, B Sauvezie, D. A. Pierce, Journal of Clinical Investigation Clinical ImmunologyRheumatologyAutoimmune DiseaseAutoantibody ProductionSjögren’s Syndrome	1980	151
Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. Makoto Goto, Minoru Sasano, Hisashi Yamanaka, Journal of Clinical Investigation Interleukin 1-Like FactorImmunologyPathologyImmunotherapyInflammation	1987	112
Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. Hitoshi Kohsaka, Kazuhiko Yamamoto, Hideyuki Fujii, Journal of Clinical Investigation Humoral ResponseImmunologyPathologyMolecular BiologyImmunodominance	1990	86
Physical and functional interactions between Stat5 and the tyrosine- phosphorylated receptors for erythropoietin and interleukin-3 Ho Jun Chin, N Nakamura, Ryuichi Kamiyama, Blood	1996	85
Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis. Sae Ochi, Toshihiro Nanki, Kazuki Takada, PubMed Radiographic ImprovementHigh-dose CorticosteroidsAllergyFavorable OutcomesPulmonary Medicine	2005	69

Page 1